The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult-Reference-Cited by-同舟云学术

The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult

Published:2022-08 Issue:8 Volume:7 Page:1878-1886
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Tedesco Martina,Mescia Federica^ORCID,Pisani Isabella,Allinovi Marco^ORCID,Casazza Giovanni,Del Vecchio Lucia,Santostefano Marisa,Cirillo Luigi,Ferrario Francesca,Esposito Ciro,Esposito Pasquale,Santoro Domenico,Lazzarin Roberta,Rossi Giovanni Maria,Fiaccadori Enrico,Ferrantelli Angelo,Sinico Renato Alberto,Cozzolino Mario,Gallieni Maurizio,Cirami Lino,Scolari Francesco,Vaglio Augusto,Alberici Federico,Affatato Stefania,Caroti Leonardo,Mancini Elena,Semeraro Luca,Siligato Rossella,Arnaldo Cassia Matthias,Napodano Pietro,Calatroni Marta,Distratis Cosimo,Campo Andrea

Publisher

Elsevier BV

Subject

Nephrology

Reference34 articles.

1. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States;Kitiyakara;Am J Kidney Dis,2004

2. Primary nephrotic syndrome and risks of ESKD, cardiovascular events, and death: the Kaiser Permanente nephrotic syndrome study;Go;J Am Soc Nephrol,2021

3. Immunologic changes implicated in the pathogenesis of focal segmental glomerulosclerosis;Kronbichler;BioMed Res Int,2016

4. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology;Watts;J Am Soc Nephrol,2022

5. Treatment strategies of adult primary focal segmental glomerulosclerosis: a systematic review focusing on the last two decades;Beer;BioMed Res Int,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anuria after kidney transplantation diagnosed as early recurrence of focal segmental glomerulosclerosis combined with acute calcineurin inhibitor nephrotoxicity: a case report and literature review;BMC Nephrology;2024-04-05

2. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group;Nephrology Dialysis Transplantation;2024-02-10

3. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study;American Journal of Nephrology;2023-11-14

4. Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse;Kidney International Reports;2023-11

5. Clinical advances in immunotherapy for immune-mediated glomerular diseases;Clinical and Experimental Medicine;2023-10-27